Close menu

Our network

lat=48.573405*long=7.752111*img=https://lyonbiopole.com/wp-content/uploads/2022/04/Magia2Market-4.webp*title=Magia2Market*text=*link=magia2market*link_text=Plus d'infos*link_type=anchor*icon=yellow**lat=48.579*long=7.764*img=https://lyonbiopole.com/wp-content/uploads/2022/04/S3MartMed-1.webp*title=S3martMed*text=*link=s3martmed*link_text=Plus d'infos*link_type=anchor*icon=yellow**lat=48.585*long=7.74*img=https://lyonbiopole.com/wp-content/uploads/2022/04/BioXClusters-2.webp*title=bioXclusters*text=*link=bioxclusters*link_text=Plus d'infos*link_type=anchor*icon=yellow**lat=41.382264*long=2.109299*img=https://lyonbiopole.com/wp-content/uploads/2022/04/Biocat.webp*title=Biocat*text=Biocatfait fait parti de l'alliance bioXclusters*link=https://www.biocat.cat/en*link_text=Plus d'infos*link_type=blank*icon=default**lat=48.10892*long=11.451958*img=https://lyonbiopole.com/wp-content/uploads/2022/04/BioM-1.webp*title=BioM*text=BioM fait parti de l'alliance bioXclusters*link=https://www.bio-m.org/en.html*link_text=Plus d'infos*link_type=blank*icon=default**lat=45.43283*long=7.798532*img=https://lyonbiopole.com/wp-content/uploads/2022/04/BioPMed.webp*title=BioPMed*text=BioPMed fait parti des alliances bioXclusters, Magia2Market et S3martMed*link=https://www.biopmed.eu/en/*link_text=Plus d'infos*link_type=blank*icon=default**lat=46.54243*long=6.660372*img=https://lyonbiopole.com/wp-content/uploads/2022/04/Biopole.webp*title=Biopôle*text=*link=https://www.biopole.ch/*link_text=Plus d'infos*link_type=blank*icon=default**lat=48.782312*long=9.177137*img=https://lyonbiopole.com/wp-content/uploads/2022/04/BioRegio-Stern.webp*title=BioRegio Stern*text=BioRegio Stern fait parti de l'alliance S3martMed*link=https://www.bioregio-stern.de/en*link_text=Plus d'infos*link_type=blank*icon=default**lat=50.469856*long=3.462904*img=https://lyonbiopole.com/wp-content/uploads/2022/04/BioWin.webp*title=BioWin*text=BioWin fait parti des alliances Magia2Market et S3martMed*link=https://biowin.org/fr/homepage-french/*link_text=Plus d'infos*link_type=blank*icon=default**lat=44.987339*long=-93.359241*img=https://lyonbiopole.com/wp-content/uploads/2022/04/web_logos_color.webp*title=Medical Alley*text=*link=https://medicalalley.org/*link_text=Plus d'infos*link_type=blank*icon=default**lat=50.282504*long=18.669992*img=https://lyonbiopole.com/wp-content/uploads/2022/04/MedSilesia-simple.webp*title=medSilesia*text=medSilesia fait parti de l'alliance S3martMed*link=https://medsilesia.com/*link_text=Plus d'infos*link_type=blank*icon=default**lat=50.840742*long=4.36889*img=https://lyonbiopole.com/wp-content/uploads/2022/04/CEBR.webp*title=CEBR*text=*link=https://www.cebr.net/*link_text=Plus d'infos*link_type=blank*icon=default**lat=48.189448*long=11.59136*img=https://lyonbiopole.com/wp-content/uploads/2022/04/eit-health.webp*title=eit health*text=*link=https://eithealth.eu/*link_text=Plus d'infos*link_type=blank*icon=default**lat=34.690083*long=135.195511*img=https://lyonbiopole.com/wp-content/uploads/2022/04/Kobe-biomedical-innovation-cluster.webp*title=Kobe biomedical innovation cluster*text=*link=https://www.fbri-kobe.org/kbic/english/*link_text=Plus d'infos*link_type=blank*icon=default**lat=53.590657*long=9.972327*img=https://lyonbiopole.com/wp-content/uploads/2022/04/Life-Science-Nord.webp*title=Life Science Nord*text=Life Science Nord fait parti de l'alliance Magia2Market*link=https://lifesciencenord.de/en/*link_text=Plus d'infos*link_type=blank*icon=default**lat=34.693738*long=135.502165*img=https://lyonbiopole.com/wp-content/uploads/2022/04/Osaka-Bio-Headquarters.webp*title=Osaka Bio Headquarters*text=*link=https://osaka-bio.jp/english/*link_text=Plus d'infos*link_type=blank*icon=default**lat=31.23039*long=121.473702*img=https://lyonbiopole.com/wp-content/uploads/2022/04/BJICI.webp*title=Shangai medical instrumentation trade association*text=*link=https://www.bjici.net*link_text=Plus d'infos*link_type=blank*icon=default**lat=39.952584*long=-75.165222*img=https://lyonbiopole.com/wp-content/uploads/2022/04/logo-wistar-institute.webp*title=The Winstar institute*text=*link=https://wistar.org/*link_text=Plus d'infos*link_type=blank*icon=default**lat=45.501689*long=-73.567256*img=https://lyonbiopole.com/wp-content/uploads/2022/04/Montreal-in-vivo.webp*title=Montreal in vivo*text=*link=https://www.montreal-invivo.com/*link_text=Plus d'infos*link_type=blank*icon=default

European alliances
 
 

Bioxclusters alliance

The bioXclusters Alliance works on personalised medicine and aims to put European biotech SMEs on strategic international markets through the use of shared tools and the creation of links with local organisations. The six markets targeted are the United States, Brazil, China, Japan, Canada and South Korea.

 

The emergence and development of this Alliance was made possible through the European bioXclusters (2012-2014) and bioXclusters Plus (2016-2018) projects, co-financed by the European Commission as part of the COSME programme (Competitiveness for SMEs).

 

The bioXclusters Alliance brings together three partner clusters in Europe recognised in the personalised medicine sector at Lyonbiopole:

Magia alliance

The MAGIA Alliance works in the field of medical technology with the aim of supporting European medtech SMEs to expand internationally into the Chinese, US and Japanese markets, and to increase the international visibility of the European medtech industry.

 

The emergence and development of the Alliance was made possible through the European MAGIA (2018-2020) and MAGIA2Market (2020 – ongoing) projects, co-financed by the European Union, as part of the COSME programme (Competitiveness for SMEs).

 

The MAGIA Alliance brings together three partner clusters in Europe recognised in the medical technology sector at Lyonbiopole:

S3martMed Alliance

The S3martmed Alliance operates in the field of medical technology with the aim to promote interactions and collaborations between key players from five European regions, to strengthen the Smart Specialisation policy of the regions involved and to support inter-regional investments in medical technologies.

 

The emergence and development of the Alliance was made possible through the European S3martMed (2018-2020) project, co-financed by the European Union, as part of the COSME programme (Competitiveness for SMEs).

 

The S3martMed Alliance groups together four partner clusters in Europe recognised in the medical technology sector at Lyonbiopole: